INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 15, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Nov 15, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Nov 14, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | -- | -- |
| Sep 08, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Sep 06, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 82,818 | -- | -- |
| Apr 05, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Apr 04, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 92,308 | -- | -- |
| Mar 31, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Mar 30, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,692 | -- | -- |
| Dec 14, 2010 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,264 | -- | 3,264 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.